The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| JAPA.Y | +26.9% | +84.09% | +12.97% | +55% |
| S&P | +19.89% | +109.18% | +15.89% | +248% |
Japan Tobacco, Inc. engages in the manufacture and sale of tobacco, pharmaceutical and processed food products. It operates through the following divisions: Japanese Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. The Japanese Domestic segment deals with the production and sale of tobacco products in domestic areas. The International Tobacco segment manufactures and markets tobacco products worldwide. The Pharmaceutical segment develops, manufactures, and sells prescription drugs. The Processed Food segment offers processed food, bakery products and seasonings. The company was founded on April 1, 1985 and is headquartered in Tokyo, Japan.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $6.28B | 18.0% |
| Gross Profit | $3.62B | 27.6% |
| Gross Margin | 57.63% | 4.4% |
| Market Cap | $52.20B | 8.6% |
| Market Cap / Employee | $0.97M | 0.0% |
| Employees | 53.6K | 0.7% |
| Net Income | $1.13B | 18.2% |
| EBITDA | $1.88B | 17.1% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $5.99B | -11.4% |
| Accounts Receivable | $4.02B | -1.6% |
| Inventory | 6.7K | 13.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $9.97B | 49.0% |
| Short Term Debt | $1.29B | 171.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 2.54% | -4.4% |
| Return On Invested Capital | 8.46% | -1.4% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $995.70M | -9.6% |
| Operating Free Cash Flow | $1.17B | -9.4% |
| Metric | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 14.31 | 16.21 | 41.57 | 38.68 | 181.50% |
| Price to Book | 1.87 | 1.67 | 1.89 | 2.06 | 13.11% |
| Price to Sales | 2.37 | 2.54 | 2.30 | 2.35 | 0.52% |
| Price to Tangible Book Value | 6.28 | 5.73 | 20.94 | 18.69 | 173.29% |
| Price to Free Cash Flow TTM | 41.59 | 31692.25 | 79.34 | 116.06 | 154.84% |
| Enterprise Value to EBITDA | 30.81 | -29.75 | 28.83 | 30.81 | 0.20% |
| Free Cash Flow Yield | 2.4% | 0.0% | 1.3% | 0.9% | -60.76% |
| Return on Equity | 12.0% | 4.7% | 4.5% | 4.8% | -60.71% |
| Total Debt | $7.54B | $11.39B | $11.14B | $11.26B | 57.16% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
